Amrutkar M, Guttorm SJT, Labori KJ, Rootwelt H, Elgstøen KBP, Gladhaug IP, Verbeke CS(2026) Reduced lipid metabolite abundance in human pancreatic cancer and matched serum samples following neoadjuvant FOLFIRINOX treatment Metabolomics, 22(1), 18 DOI 10.1007/s11306-025-02388-z, PubMed 41553593
Følling I, Selle ML, Nilsen HR, Wennerström AB, Nilsen HL, Eide TJ(2026) Distribution of glucagon-like peptide 1 receptor and insulin in phaeochromocytomas Endocr Connect, 15(1) DOI 10.1530/EC-25-0338, PubMed 41488993
Langtry A, Rabadan R, Alonso L, Filip I, Sabroso-Lasa S, Moreno-Oya A, Lawlor R, Carrato A, Alvarez-Gallego R, Iglesias M, Molero X, Löhr MJ, Michalski CW, Perea J, O'Rorke M, Barberà VM, Tardón A, Farré A, Muñoz-Bellvís L, Crnogorac-Jurcevic T, Domínguez-Muñoz E, Gress TM, Greenhalf W, Sharp L, Balsells Jet al.(2025) Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis Nat Commun, 16(1), 10769 DOI 10.1038/s41467-025-65811-y, PubMed 41315260
